SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings and guidance are the main focus, with traders watching for signs that engagement, subscriber growth and advertising can offset concerns about content quality, recent layoffs and the content leadership change. Views are split between traders bracing for another post-earnings drop and bulls arguing that pessimism is already reflected in the share price.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas plans to pursue a public listing for fintech arm Monee and launch Sea Cloud are fueling concern about spending and uncertainty. Traders largely blame the developments for the selloff, while some see a Monee listing as a potential way to unlock value for shareholders.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally and stronger volume have fueled talk of a technical reversal, with traders pointing to chart patterns and a possible breakout. Bulls see renewed momentum, while skeptics question whether the move can hold given COMPs history of lagging other crypto assets.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Upcoming MSToronto clinical presentations are driving attention, especially initial Phase 1 azer-cel results in progressive MS alongside BRIUMVI data on long-term outcomes and dosing. Traders are broadly optimistic about the catalyst-rich pipeline and BRIUMVIs commercial growth, while some caution that azer-cel is early-stage and debate the stocks muted trading; buyout speculation remains unconfirmed.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports shares are drawing attention after RAP-219s Phase 2 bipolar-mania trial met its primary and secondary endpoints, prompting bullish reactions and analyst upgrades. Traders are debating whether the efficacy signal is strong enough to justify the surge, citing the modest placebo-adjusted improvement, higher discontinuation rate, and the stocks sharp retreat after its initial jump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocktwits Weekly Spread: What Shaped Treasury Yields And The Dollar This Week  

Equity

An accelerating rout in AI stocks sent the U.S. dollar to its worst weekly drop in a month while Treasuries resumed their slide for the week ending Oct. 16. 


Pimco ETF Trust - PIMCO Active Bond ETF

Neutral Sentiment

<ul class="summary-bullets"><li>The U.S. dollar index dropped 0.2% on Friday, completing its sharpest weekly decline since early September as traders lowered probabilities of an October rate hike to 20%.</li><li>The U.S. Treasury Department released primary dealer survey questions that omitted direct references to cutting 20-year bond issuances or scaling back long-end debt auctions.&nbsp;</li><li>The yield curve flattened further this week, with 10-year yields falling about 16 basis points over the previous week.</li></ul><p>U.S. government bond prices retreated, and the dollar suffered its sharpest weekly decline in over a month during the week ending&nbsp;Oct. 16, as fixed-income investors digested ambiguous signals from Kevin Warsh on the future course of interest rates.&nbsp;</p><p>Federal Reserve Chairman Kevin Warsh declined to provide forward guidance on interest rate trajectory during remarks at the International Monetary Fund meetings in Bangkok. Warsh's silence led traders to pare back probabilities of an October rate hike to 20%.&nbsp;</p><p>"Warsh offered no guidance, which while it should be expected of him at this point, the market is taking it as a signal that the October Fed meeting is likely a no go," Noah Buffam at CIVB Capital Markets told Bloomberg in an interview.&nbsp;</p><p>Moreover, adding to the dissent among fixed income traders, the U.S. Department of the Treasury did not provide information or explicit proposals to reduce long-duration debt issuances or eliminate 20-year auctions, which primary dealers were expecting.</p><p>The 30-year U.S. Treasury yield slipped 17 basis points from the previous week to 5.43%, while the 10-year yield eased slightly to 5.08% and 2-year yields settled at 4.72% for the week ending Oct. 16.</p><p>The spread between the U.S.&nbsp;10-year&nbsp;yield and the U.S.&nbsp;2-year&nbsp;yield ticked lower to 0.37% in the week, from 0.44% a week ago.</p><p>The iShares 20+ Year Treasury ETF (<a class="mention" data-mention="$TLT" data-symbol-id="TLT" href="https://stocktwits.com/symbol/TLT" target="_blank">TLT</a>) ended the week 2.7% higher, while the shorter-duration iShares 1-3 year ETF (SHY) added about 0.2%. The slight recovery in the shorter-duration bond ETF may reflect easing short-term inflation pressure; however, markets still factor in one more rate hike in December.&nbsp;&nbsp;</p><p>Retail sentiment on TLT and SHY was ‘bullish,’ with ‘high’ message volumes.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Asset / Benchmark&nbsp;</td><td>Weekly Close&nbsp;</td><td>Weekly Change&nbsp;</td></tr><tr><td>U.S. Dollar Index&nbsp;</td><td>101.78&nbsp;</td><td>-0.3%&nbsp;</td></tr><tr><td>U.S. 2-Year Treasury Yield&nbsp;</td><td>4.72%&nbsp;</td><td>-7 bps&nbsp;</td></tr><tr><td>U.S. 10-Year Treasury Yield&nbsp;</td><td>5.08%</td><td>-16 bps&nbsp;</td></tr><tr><td>U.S. 30-Year Treasury Yield&nbsp;</td><td>5.42%</td><td>-17 bps&nbsp;</td></tr><tr><td>U.S. 10Y2Y Yield Spread&nbsp;</td><td>Flattening curve</td><td>-</td></tr></tbody></table></figure></div><h2 class="st-heading-2"><strong>Yield Curve &amp; Global Sovereign Markets&nbsp;</strong></h2><p>Yield curve flattening trends persisted as short-duration yields outpaced gains at the long end, keeping the gap between 2-year and 10-year Treasuries tightly compressed.</p><p><img src="https://news.stocktwits-cdn.com/koyfin_20261017_054625677_be83e32d82.png" alt="koyfin_20261017_054625677.png"></p><p>The bond rout expanded across international sovereign bond markets. European government bond yields rose alongside U.S. peers, with German Bunds, UK Gilts and French bonds all remaining elevated amid soaring inflation pressures.&nbsp;</p><h2 class="st-heading-2"><strong>Greenback &amp; Economic Data Roundup</strong></h2><p>The Dollar Spot Index slipped 0.2% on Friday, snapping a multi-week rally and registering its worst weekly performance since September 4. The dollar fell against all major developed market currencies, allowing the euro to break a five-week losing streak.&nbsp;</p><p>Hotter-than-expected September CPI data and solid retail sales initially supported rate-hike expectations earlier in the week, but investors questioned the durability of the artificial intelligence boom that has supported U.S. growth, putting pressure on the greenback.&nbsp;</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

A trader works on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on March 24, 2026. European and US stocks resumed sliding and oil prices jumped on Tuesday as traders turned cautious over the prospect of a negotiated agreement between the United States and Iran to end the Middle East war. (Photo by ANGELA WEISS / AFP via Getty Images)

U.S. government bond prices retreated, and the dollar suffered its sharpest weekly decline in over a month during the week ending Oct. 16, as fixed-income investors digested ambiguous signals from Kevin Warsh on the future course of interest rates.

Stocktwits Weekly Spread: What Shaped Treasury Yields And The Dollar This Week

Pimco Exchange Traded Fund - PIMCO Active Bond ETF

iShares U.S. Treasury Bond ETF

iShares 1-3 Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$87.73
Prev Close	$87.60
Open	$87.72
Dividend Yield	N/A
50-Day Moving Average	$88.92
Beta	N/A
Avg. Volume	997,798.80
PE Ratio	N/A

52-Week High	$94.68
52-Week Low	$86.11
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

BOND Fundamentals